MyMD Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $; its P/E ratio is ―; MyMD Pharmaceuticals is scheduled to report earnings on May 20, 2019, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Income Statement	-
Total Revenue	-	-	-	-	$ 0.00
Gross Profit	-	-	-	-	$ 0.00
EBIT	$ 4.04M	$ -4.17M	$ -1.51M	$ -3.75M	$ -3.69M
EBITDA	$ 4.04M	$ -4.17M	$ -1.51M	$ -3.75M	$ -3.69M
Net Income Common Stockholders	$ 2.88M	$ -4.54M	$ -97.00K	$ -3.75M	$ -3.69M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 8.47M	$ 11.63M	$ 15.55M	$ 4.84M	$ 7.08M
Total Assets	$ 21.83M	$ 25.25M	$ 28.41M	$ 17.54M	$ 20.23M
Total Debt	$ 72.63K	$ 109.79K	$ 126.03K	$ 141.72K	$ 156.77K
Net Debt	$ -8.40M	$ -11.52M	$ -15.42M	$ -4.69M	$ -6.93M
Total Liabilities	$ 5.72M	$ 14.48M	$ 14.40M	$ 2.84M	$ 1.90M
Stockholders Equity	$ 15.50M	$ 10.74M	$ 13.09M	$ 14.70M	$ 18.33M
Cash Flow	-
Free Cash Flow	$ -3.16M	$ -3.92M	$ -3.97M	$ -2.25M	$ -4.09M
Operating Cash Flow	$ -3.16M	$ -3.92M	$ -3.97M	$ -2.25M	$ -4.09M
Investing Cash Flow	$ 3.36M	$ 3.83M	$ -11.27M	$ 2.69M	$ -2.27M
Financing Cash Flow	-	-	$ 14.69M	-	$ 5.55M

Currency in USD

MyMD Pharmaceuticals Earnings and Revenue History

Income Statement >

MyMD Pharmaceuticals Debt to Assets

Balance Sheet >

MyMD Pharmaceuticals Cash Flow

Cash Flow >

MyMD Pharmaceuticals Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing